Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey Phd and other longs. Honest question….. What do we as shareholders really expect DD to say?
We all know he CANNOT say anything not issued in a PR or it could be considered insider information. I also emailed him, and I did get a reply, but the reply was the standard “Unfortunately, we are obliged to refrain from any communications beyond our public disclosures. To do so would bring swift action from the government regulators.”
I would also guess that when he sees multiple emails from the same person, often times complaining, he ignores them. The company even addresses that in a shareholder update.
I know we are all starved for information that will move the PPS. I suspect they are too, but won't compromise their position by putting our what half this message board would call a fluff PR. The bottom line is we are not likely to see a PR of "Kits sold" or "patients treated" and tangible "numbers" that the market would like.
What we will have to learn to live with is watching the revenue grow in the Q's and let the PPS grow organically. I actually like the fact that they are not your normal OTC we are all used too. This baby is very different, and that is a GOOD thing :)
Joh64. Many of us fully agree. The PPS here is ridiculous and won’t last long IMO
Ummmm. It was a green sled today.
Speaking of facts..... The trade posted after the bell was NOT a T Trade. Even iHub doesn’t show it as a T Trade. It has zero "conditions" tied to it per several indicators. Just sayin since you want facts.
Hey Miggy, I know your timing was a little off last summer, but so where many of my buys. We all had excitement watching doctors show interest after the AUA, and the DD of finding all the domain addresses and we bought and added into the run and chased. We could debate all evening on why we lost our momo in the fall and fell back to .01, but here we sit.
But can’t you feel that excitement coming back? We can see that many of the interested doctors did sign up and got their offices up and running and began treating patients. That is proof of concept for me.
We also saw CELZ improve on many levels. Just to name a few.....
CELZ improved CaverStem and dropped the need for the doctors having to buy and use a centrifuge machine, now only needing the needle kit. CELZ cleared their international hurdles and got the ball rolling in Russia and signed up Dr Antonini in Rome and last we heard were scheduling training in Switzerland.
CELZ started advertising as they said they would, filed a few more patents, and started a physician awareness campaign.
CELZ started commercialization of FemCelz and patients are scheduled to be treated this month.
CELZ is stiill burning cash to do all of this, but they were able to engage institutional investors to soften the blow with better conditions, and even renegotiated the most recent notes.
People who call CELZ hear that patients are calling, traveling to be treated, and that things are really picking up steam.
With all of that in mind, and seeing it happening, don’t you feel any of the excitement we had last summer?
I can’t see .01 lasting forever. I hope you see it too.
He is in a roll. It is an interesting question, really. The other fella demands proof, so touché
Crunch time ;)
To use your own words, I’d does say allegedly ;)
All over the internet my friend.
For most of us gint ;)
Glad to see all the excitement starting......
Weeeeeeeeeeeeeeeeeeeeee
More and more calls, more and more treatments, more and more revenue. NO coincidence :)
Thanks Yooperman, and I agree 100% that the PPS is confusing. We all know there are notes that are clearing, the bad side of any startup, and luckily most are held by the Institutional Investors and they have trickle out clauses.
I am somewhat confused as to why buying has slowed so much, but I agree with the poster this week that said there are many eyes on CELZ waiting to time it. Lots of folks “staying in cash” waiting for the right signal.
not knowing if that signal will come in a day or two, a week or two, or a month or two is what is causing many to watch and try to time it IMHO.
I also truly think it is vastly unknown by watching the traffic even here on this blog.
But I have no doubt that CELZ will NOT stay unknown for long, and when this heats up we will surpass the previous highs.
Here what I like when I read the tea leaves. Some will call CELZ a scam, nothing to back up their claims of success, just a share selling scheme etc etc.
But what I have seen from the the DD I have done is that Dr Bieri retired from him practice, Dr Said is basically doing double duty, and they both spent a TON of cash to not only offer CaverStem, but to start an entire stem cell clinic dedicated to CaverStem and regenerative health.
They have dedicated their careers and put their money where there mouth is so to say, to first providing CaverStem and now FemCelz and I am sure in the future, the other stem cell treatments that CMTH is developing, patenting and trademarking.
Common sense tells you they have done their homework, have seen the evidence and know what they are doing!
Now you see a further financial commitment to advertising and building their practice. ALL of this will build their practice and provide a steady revenue stream for CMTH.
Seeing this kind of commitment to the products provided by the company I am investing in is VERY comforting. Follow the money folks.
Always moving forward. Great info. Thanks
Miggy, I just posted this a few days ago, so forgive me if you already saw it. It explains why I am very positive in what CELZ has going for it. I have to run in a minute and will address my thoughts on the other post from this morning, but I saw far more good in it than bad. In short, IMHO, the call taker should have referred Meat to one of the offices to discuss his concerns with a doctor, not the COO. After all, he called inquiring about the treatment, not as an investor if I remember correctly. She should not have told any caller that the CEO or COO would call back. She over promised, not Don. I am glad Don did not call back, because as soon as the topic shifted to the stock performance the call would have ended quick and the caller would have been frustrated either way IMHO. I hope Don and Tim and all of them are too busy to chat. Yes, they need a dedicated Investors Relations person, but even then, we all know they are severely limited in what they can say. What I loved was the quote that CaverStem is taking off. Many of us see that. The PPS will find itself sooner or later IMO....
Here is the reasons for my confidence......
This is what the INVESTORS KNOW about CMTH.......but don't trust me or anyone on the blog. Do you own DD please, and you too will KNOW......
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations.
Dr. Antonini from Italy has also began treating patients in 2019 and we know patients were treated in Russia. CELZ reported that three more doctors are scheduled for training in March and April.
Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails.
CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting an advertising campaign in Los Angeles and will be the first city to expand into print and TV.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…90% success rate, even in difficult patients.
A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14 Please review this. You will be surprised by the patients ages IMO.
Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors.
CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program.
CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. in Q1 2019. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands.
CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH. 4 NEW patents were applied for in 2018.
Gershman and Ichim have already successfully commercialized Medistem.
CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
We KNOW CaverStem + StemSpine + AmnioStem = NASDAQ
PLEASE read the sticky posts seen when logging in to iHub through a browser!!
Has it been disproven? It’s says call them today for info. You can add that call to your list of calls you are behind on.
Spot on. +10
Denying that a patient was successfully treated with anything because of a typo is just silly.
I see typos in the newspaper all the time. Does that mean the news event did not happen???LOL
The patient was administered one tablet of Vocodin (7.5 mg hydrocodone) and one tablet of Xanax (1 mg) 30 minutes before the procedure. Local lidocaine was applied topically at the area of bone marrow puncture. A total of 60 ml of bone marrow aspirate was obtained and processed in a closed-system bone marrow concentration device. Bone marrow mononuclear cells were concentrated to a volume of 2 ml, with 1 ml administered into each cavernousal body using a 25 gauge syringe. A tourniquet was placed around the base of the penis during the injection procedure and held for 5 minutes to allow for maximal retention.
No immediate injection-associated adverse events were noted. The patient reported a morning erection 2 days after cell administration. Although angiogenesis could not occur during this short time period, the possibility of bone marrow released nitric oxide stimulating erections via vasodilation may be postulated [166]. Three weeks after treatment, the patient reported erection strong enough for penetration, but did not have ability to sustain the erection until orgasm. At three month follow-up the patient reported having intercourse until orgasm several times and a marked increase in morning erections. Importantly, no adverse effects or ectopic tissue formation was observed at the 3, 12 and 18 month follow-up. At last visit, 18 months after procedure, the patient still reported improved sexual function as compared to prior to treatment.
Hey JDFF.... Do you think the patient cared about a misspelling? Their pecker started working again...mic drop.
You bet. Good to see you doing some DD here.
I agree with everything you said, including your time frames. I would just also add that something little could entice a group to swoop in before that happens and like SFT has said, the volume will come out of no where. The paper being published, the three new docs being announced, a better Q4 than we think, the acquisition or something else could do it.
Buying lately has been almost nonexistent, so imagine a few 20-50 million trade days strung together.
Good post. It will take time to ramp up for sure. I bet we see doctors and patients getting on board faster and faster as the year progresses and as CMTH works out the kinks. The potential here is incredible and at this PPS, it’s a no brainer IMO. The company will take time to get big, but like was posted this morning, any time awareness could cause significant buying at this level and a big boost in PPS. We see stocks run in the OTC with less going for them all the time.
It’s been well established that each patient treated corresponds to a $1600 kit sourced from CELZ. Now, what we don’t know, or at least I don’t know for certain, is how much CELZ pays for the kit? The difference being their profit.
So, ALL of the CaverStem and FemCelz treated patients will generate revenue. We will see the numbers at each Q.
When the 10k hits this month it will only show last year, so yes, we will be waiting for Q1 this year to see the revenue from these new offices opening.
As we have all speculated, that will be Q after Q growth for a while as patient numbers and office numbers expand.
The next question for me is, when do we see either news or market awareness that causes a frenzy on buying?
Could be MM, but here is a tidbit. FemCelz patients on deck for next week!!
FemCelz will be scheduled at our Regenerative Medical Health Center. It is beginning in California next week.
— Elias Said, MD, FACEP (@MdFacep) March 13, 2019
FemCelz ™ : FDA-cleared technology Using your Stem Cells to rejuvenated your sexual health@CaverStem @GershmanMDLA @antoniniurology @CSUF_Phoenix pic.twitter.com/11Uw4yRund
Welcome back Miggy!
Doesn’t matter to me Wolf. I am confident it’s will go up so I hold. since you are so confident we are dropping I assumed you would cut your losses, sell and get back it at your target. Lord knows you try to discourage anyone from buying which is self destructive IMO. I was just curious. Off duty from my paid pumping for a bit. Play nice.
Yup, like I said yesterday, we are way over due and in the dark on Russia and even Switzerland.
So, you sold then?
ABSOLUTELY WRONG. We received FemCelz news just a day or two ago. I already linked it twice. I am sorry it’s not what you want to read. But you are being disingenuous. And we get a shareholder update almost monthly. Sheesh.
I would like to see significant news as much as the next long, and NO disrespect to CF or any traders here, but IMHO, I don’t think hammering the COO for more frequent news will (a) do anything, or (b) could be detrimental. CELZ is letting out facts as they see fit, either through the shareholder updates or the Social Media posts. When big enough news is ready, I am certain they will release it.
The last time we hammered him with email we got the following in a shareholder update…. “Again, in response to direct inquiries from shareholders seeking specific information on operating activities, it is our policy to release information via press releases and SEC filings. We understand the desire for real time information, however information must be properly disclosed to the public. Advanced information provided to individuals could present an unfair advantage and thus cannot be disclosed. We appreciate our shareholders understanding of our policy to comply with all regulations on this matter.”
One of the things I like best about CELZ is that the CEO and COO are NOT Chummy with investors and reply. That would be a red flag IMHO.
Let’s see who the next three doctors are that will be trained this month and April. Are they new names, or old names? And does it matter?
I think CELZ is charging ahead just fine, albeit slower than many would like. The PPS is a HUGE point of disagreement, but good or bad, it won’t stay here long. You know my chips are pushed to the middle of the table :) I keep thinking Medistem ;)
CMTH is a mansion being built on a large piece of prime property on a beautiful lake. This mansion is big, complex and modern inside with many ground breaking patented features, it has taken years to build. There may have been permitting issues, cost overruns, inspection issues and a host of normal construction problems, but it is being built magnificently nonetheless.
There is great interest in the mansion. Seeing it, many are now interested in the property too, and many are angry and disappointed they didn’t find the location and design the mansion first. The other folks with mansions on the same lake are worried because this mansion will be nicer than theirs and will steal all the attention away from them.
Many are so angry and disappointed that their new neighbor will have the nicest, newest, most modern house, they talk bad about it and call it gaudy, ugly, not built right and will never be nice and even that the builder has broken windows at his office.
Laughing, the owners sit back and patiently wait for it to be completed. They know how nice and groundbreaking it will be. They have no interest in selling it to any other interested parties, because it’s their design, their trademark so to say, and it will be theirs forever.
When it is finally built, and they get their occupancy permit, move in and finish the smallest of details, we will discover it will become one of the finest mansion ever built. Many will admire it, be proud of it, and even feel they had a small part of building it.
Many others will continue to talk bad about it, talk about the owners old address and where he came from, but the owner will always smile ;)
Especially when they have plans to expand the mansion as the years go by.
It hasn’t yet, but it will be additional revenue when we see the filings, and further verification (for me anyway) that the company is commercializing TWO new stem cell treatments and within short notice, patients are calling and seeking treatment.
I think it is HUGE news on what CMTH is doing.
But like I have said before. Look at the likes. Who is seeing this? Not enough people I think we would ALL agree.
When the banner ads hit the right awareness or the TV ads do that, or the filing reaches the masses..... hold on tight IMO
We are in, and have been, in the infancy start up stages!
Hey Wolf, I come bearing a message from a Star from far reaching spaces .....
One “Lone” problem with this perspective about denial and longs. Isn’t this an oxymoron? Aren’t “Longs” inherently…er…LONG? What does this really mean??? Well in the OTC land, it is like an alien visiting from a far far away galaxy. Let’s call that galaxy “intelligent land of intelligence” and in that land, when one finds something with POTENTIAL value, one takes a piece and then WAITS for as long as it takes to see if the POTENTIAL ever comes. If it does then great! If it doesn’t then try again. Either way, it isn’t “denial” when you make a LONG bet on the POTENTIAL of a play. Fliptards and OTC permanent residents cannot comprende and never will.
All hail the LONG CELZY song!
Not this one. I 1000% agree it’s being held down. I hate it too, but have taken advantage of it.
Just clarifying. This does not count because it’s not in the shape of a PR or 8k? Is this not direct correspondence from the company?
https://www.facebook.com/310132649644913/posts/319361628722015?sfns=mo
FemCelz scheduling the first patient is NO NEWS? How so?
Nice catch NSX. That would not surprise me in the least. I am Uber confident that these doctors and scientists are working daily on improving all of the treatments.